Doron Therapeutics
PrivateLast Round
Series A
Nov 25, 2024
Total Funding Raised
$11M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Doron Therapeutics is a clinical-stage biotechnology company developing biologic therapies for osteoarthritis. The company's lead product, MOTYS™, is a Phase 3-ready intra-articular biologic drug derived from placental tissue designed to treat knee osteoarthritis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Doron Therapeutics Comparables
Compare Doron Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genascence Corporation | 83% | |
| 4Moving Biotech | 82% | |
| Levicept | 81% | |
Doron Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 25, 2024 |
Doron Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPRIM Global Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 174% MoM.
- Nov 25, 2024
$11M round led by SPRIM Global Investments
Doron Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Doron Therapeutics's valuation, stock price, and market status.